文献速递细菌感染、耐药与抗菌药物新发突发、热带与寄生虫病

性传播耐药志贺菌病在英格兰的基因组流行病学传播研究

The spread of sexually transmissible drug-resistant shigellosis in England: a genomic epidemiology study.
PubMed 文献 · Lancet Infect Dis · 2026-07-08

该基因组流行病学研究纳入2004年9月20日至2020年2月28日英国国家监测的3514株宋内志贺菌,比较推定MSM、非MSM与高风险旅行相关病例的空间传播与传播强度。结果显示性传播菌株空间播散更广、传播更强且相对适应度更高,阿奇霉素耐药适应度在pMSM中更高。

要点

  • 性传播宋内志贺菌较其他本土菌株空间播散更广、传播更强。
  • 性传播菌株相对适应度更高,阿奇霉素耐药在pMSM中适应度更强。
  • 传统洗手与食品卫生干预可能无法阻断性传播,需替代干预。

核心结论

  • 性传播志贺菌病传播加剧且独特,应作为独立健康威胁应对。
  • 传统肠道病干预难以影响性传播,公共卫生管理存在关键空白。
  • 治疗指南驱动的旁观者耐药提示需在公共卫生层面加强抗菌药物管理。

研究设计与样本

  • 基因组流行病学研究,分析英国15个卫生区域138家实验室上报的国家监测宋内志贺菌分离株。
  • 主分析纳入2004年9月20日至2020年2月28日英国国家基因组监测的宋内志贺菌分离株,共3514株。
  • 采用系统动力学与地理空间建模,比较各人群组的地理播散与传播强度(主要结局)。
  • 次要分析评估2016年1月1日至2021年12月30日英格兰收集的468株广泛耐药宋内志贺菌分支的出现。
  • pMSM定义为16-60岁、近28天无非洲、亚洲或拉丁美洲和加勒比高风险旅行史的男性。

主要发现

  • 3514株中pMSM 1197株(34·1%)、非pMSM 1269株(36·1%)、高风险旅行1048株(29·8%)。
  • 进化时间≤2·5年平均成对空间距离:pMSM 117·4 km(95%CI 100·7-132·3),非pMSM 45·8 km(32·6-62·1),p<0·0001。
  • 性传播菌株传播更强,给定人口规模下多100条传播链(95%CI 41-171),p=0·0020。
  • 性传播分离株相对适应度为高风险旅行株的1·15倍(95%可信区间1·08-1·23)。
  • pMSM中阿奇霉素耐药相对适应度为1·71(1·59-1·84),高于非pMSM与高风险旅行组。

关键数值与推荐

  • pMSM空间播散平均成对距离117·4 km(95%CI 100·7-132·3),高于非pMSM的45·8 km(32·6-62·1)。
  • 性传播传播强度较高:给定人口规模下多100条传播链(95%CI 41-171),p=0·0020。
  • 性传播分离株相对适应度为高风险旅行株的1·15倍(95%可信区间1·08-1·23)。
  • pMSM中阿奇霉素耐药相对适应度1·71(1·59-1·84),且下降与淋病治疗政策变化重合。
  • 468株次要分析显示病原体出现与头孢曲松耐药相关。

临床怎么用

  • 应将性传播志贺菌病作为独立健康威胁识别与管理。
  • 不宜仅依赖洗手与食品卫生等传统肠道病干预来阻断性传播。
  • 需开发针对性传播的替代干预,并在公共卫生层面跨病原管理抗菌药物使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Shigellosis, caused by Shigella bacteria, is a leading cause of diarrhoeal disease globally. In the last two decades, Shigella circulation in high-income countries has expanded from being a sporadic travel-associated illness to also being an endemic sexually transmissible illness among men who have sex with men (MSM). We aimed to characterise the nature and drivers of this multimodal Shigella transmission in a high-income setting. METHODS: In this genomic epidemiology study, we used Shigella sonnei isolates referred for national surveillance from 138 laboratories across 15 UK health regions. Cases that had recent (defined as in the past 28 days) travel to Africa, Asia, or Latin America and the Caribbean were defined as high-risk travel-associated cases. Presumptive MSM (pMSM) cases were defined as men aged 16-60 years without recent high-risk travel history. Non-pMSM were defined as cases that were not pMSM or high-risk travel. We implemented phylodynamic and geospatial modelling on national genomic surveillance data of S sonnei isolates collected in the UK between Sept 20, 2004, and Feb 28, 2020, to quantitate and compare geospatial spread and transmission intensity of S sonnei across demographic groups (the primary outcome). We also determined the relative influence of antimicrobial resistance on pathogen dynamics in these demographic groups and evaluate the emergence of an extensively drug-resistant S sonnei clade collected in England between Jan 1, 2016, and Dec 30, 2021, as a secondary analysis. FINDINGS: 3514 isolates were collected during the study period. Of these isolates, 1197 (34·1%) came from pMSM, 1269 (36·1%) from non-pMSM, and 1048 (29·8%) from high-risk travel. We found that sexually transmitted S sonnei spread more rapidly (ie, had a greater mean pairwise spatial distance after 2·5 years or less of evolutionary time: pMSM 117·4 km [95% CI 100·7-132·3], non-pMSM 45·8 km [32·6-62·1], p<0·0001) and transmitted more intensely (100 more transmission chains for a given population size [95% CI 41-171], p=0·0020) than other domestically acquired S sonnei. Isolates deriving from sexually transmitted shigellosis also had greater relative fitness and were 1·15 (95% credible interval 1·08-1·23) times as fit as isolates from high-risk travel transmission. The relative fitness of azithromycin resistance among pMSM was greater (1·71 relative growth [1·59-1·84]) than in either non-pMSM or high-risk travel demographics, and that declines of azithromycin fitness in sexual transmission networks coincided with changes in treatment policies for gonorrhoea. In a secondary analysis of 468 isolates, pathogen emergence was associated with resistance to ceftriaxone. INTERPRETATION: Our study shows the distinct and intensifying sexual transmission of shigellosis, highlighting the urgent need to address sexually transmissible shigellosis as a distinct health threat. Traditional interventions for enteric diseases, such as handwashing and food hygiene practices, are not likely to affect sexual transmission of shigellosis, highlighting a crucial gap in public health management. The development of alternative interventions to address this public health threat is urgently needed. Furthermore, the unequivocal evidence of bystander resistance driven by treatment guidelines in a syndemic setting underscores the need to better manage antimicrobial stewardship across pathogens at a public health level. FUNDING: The UK Biotechnology and Biological Sciences Research Council, the UK Research and Innovation Medical Research Council, National Institute for Health and Care Research Health Protection Research Unit in Gastrointestinal Infections at the University of Liverpool, and the Eidgenössische Technische Hochschule Zürich Postdoctoral Fellowship Programme.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Marshall JE, Lefrancq N, Mason LCE, et al. The spread of sexually transmissible drug-resistant shigellosis in England: a genomic epidemiology study. Lancet Infect Dis. 2026. PMID: 42419333. doi:10.1016/S1473-3099(26)00227-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。